DASPL Class II Capsule Projects

In this session, the class of leaders through the ASPL Diplomat, American Society for Pharmacy Law program will each provide a capsule presentation of their year-long project for the ASPL leadership program. Candidates were required to study an area in pharmacy and/or pharmacy law that was of interest to the profession of pharmacy and their own professional backgrounds.

Name: Teri Miller/Kim Burns
Work Title: Asst. Clinical Professor/Professor
Title of the Capsule Project: Teaching Effective Pharmacy Law in Distance Education... Mission Impossible?
Project: Navigating “effective” jurisprudence instruction in the diverse student landscape of multi-pathway pharmacy education is challenging at best. This session will examine the dilemma, suggest integrative solutions, and look at the horizon of potential standardization with the Uniform Pharmacy Jurisprudence Exam.

Name: Jennifer Cyr/Jangus Whitner
Work Title: Pharmacy Director/Director, 340B Policy & Compliance
Title of the Capsule Project: Judicial Winds of Change: Healthcare Policy Implications of the Chevron Doctrine Overturn
Project: Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc.: 1984 landmark case before Supreme Court that determined that a court should defer to an agency’s decision regarding an ambiguous statute whenever the agency’s action was reasonable, so long as it does not conflict with Congress. The FDA has used the doctrine for its decisions regarding drug approvals and CMS has relied upon it in interpreting the Medicare Act. A review of the potential impacts on our healthcare system with the overturning of Chevron.

Name: Amanda Ward
Work Title: Consultant
Title of the Capsule Project: A 50-state analysis on licensing of non-dispensing pharmacist services outside of a traditional pharmacy or pharmacist license
Project: As pharmacists continue to move beyond traditional roles in a dispensing pharmacy, state boards of pharmacy may have additional types of licensure pharmacists must have to perform those services. A review of all 50 states boards of pharmacy will reveal if the pharmacists must license their non-dispensing services as a pharmacy or if their licensure as a pharmacist is sufficient.

Name: Uzoma Anyanetu
Work Title: Pharmacy Manager
Title of the Capsule Project: Drug Discounts: Good for Whom? A Review of Cases Involving Pharmacy Drug Pricing and the FTC and the OIG.
Project: Many consumers are using discount coupons for their medications. My presentation looks at the role of the Federal Trade Commission (FTC) and medication pricing.

Name: Jonathan Keller
Work Title: Counsel, Faegre Drinker
Title of the Capsule Project: A Year in Review: Recent DEA Rules Every Pharmacist Should Know
Project: Over the last year, DEA has issued several rules regarding various aspects of the practice of pharmacy. This presentation will discuss the salient aspects of several of these rules and discuss what practicing pharmacists will need to know. Topics discussed will include (i) reporting theft or significant losses of CS, (ii) electronic transfer of CII prescriptions, (iii) partial filling of CII prescriptions, and (iv) prescribing controlled substances via telemedicine (to be issued later this year).

Name: Rachel Barenie (pre-recorded presentation)
Work Title: Assistant Professor
Title of the Capsule Project: A Scoping Review of Innovative Teachings Methods in Pharmacy Law
Project: This project will examine prior studies published on innovative teaching methods of pharmacy law to pharmacy students in the US.

Name: Lindsey Elmore
Work Title: Founder and CEO
Title of the Capsule Project: The Impact of the Inflation Reduction Act
Project: The Inflation Reduction Act is the Biden-Harris administration’s attempt to lower prescription drug pricing and healthcare costs, strengthen Medicare’s ability to negotiate drug pricing, expand access to care, reduce research gaps, and protect health care consumers from unexpected expenses. This project will review the Inflation Reduction Act’s impact on the healthcare system.

Name: Rodney Richmond
Work Title: Professor/Department Chair; President of AR Board of Pharmacy
Title of the Capsule Project: Pharmacy Political Advocacy Elective Course
Project: The aim of this project is to summarize the transformative experience of an elective course in political advocacy tailored for pharmacy students. The course design aimed to equip students with essential skills in understanding healthcare policy, engaging in advocacy efforts, and navigating legislative processes. Throughout the course, students engaged in practical exercises, collaborated with stakeholders, and delved into real-world advocacy campaigns. Key outcomes of the course include the successful passage of several healthcare-related laws influenced by student-led advocacy efforts. The course attracted a significant number of participants across each course offering, reflecting student interest in political engagement within the pharmacy profession. By empowering students with advocacy skills, the course not only enhanced their professional development but also contributed to meaningful legislative changes impacting healthcare policy. Our experience underscores the importance of integrating political advocacy education into pharmacy curricula, illustrating its profound impact on shaping future pharmacy leaders and fostering proactive engagement in healthcare policy.

Name: Lindsay Wall
Work Title: President
Title of the Capsule Project: Substance Use Disorder in the Pharmacist: A State-by-State Analysis
Project: Different state boards of pharmacy may have varying approaches to a pharmacist that has been diagnosed with substance use disorder. The two extremes include a punitive approach versus more of a recovery-focused approach.

Name: Diane Ginsburg
Work Title: Clinical Professor and Associate Dean for Healthcare Partnerships
Title of the Capsule Project: Red Flags: Variability in State Laws & Rules
Project: The term “Red Flags” is not codified in the Federal Controlled Substances Act and is also not included in the DEA Pharmacist’s Manual. Although the term red flags is considered a “term of art” there have been issues in litigation due to this term not being codified into law. Some states have included this term and/or use different terminology to direct pharmacists regarding their corresponding responsibility regarding controlled substances. The goal of this project is to determine the following: Identify what nomenclature/terminology is used in state-controlled substances acts, state pharmacy & medical practice acts, and rules and develop recommendations for pharmacy association government affairs divisions to utilize in working with DEA and DOJ to propose language changes to be included in the Federal Controlled Substances Act which would impact state practice acts.